Interestingly, a large scale clinical study has demonstrated a significant association between low IGFBP3 serum levels and cognitive impairment, independent of low IGF-I serum levels, in elderly male AD patients compared to patients with mild cognitive impairment (MCI) and normal controls [24]. The gene discussed is IGFBP3; the disease is Alzheimer disease.